Table 2 Comparison between male and female in OAG patients ≤65 yrs.
≤65 yrs OAG better eye | P-value | ≤65 yrs OAG worse eye | |||||
---|---|---|---|---|---|---|---|
All | Male | Female | Male vs Female | All | Male | Female | |
Number of patients | 124 | 54 | 70 | − | 124 | 54 | 70 |
Age (yrs) | 55.6 ± 8.4 | 55.1 ± 9.0 | 56.0 ± 7.9 | 0.86 | − | − | − |
Sex (Male:Female) | 54:70 | 54:0 | 0:70 | − | − | − | − |
NTG:POAG | 88:36 | 38:16 | 50:20 | 0.84* | − | − | − |
dROM (U.CARR) | 343.8 ± 55.9 | 339.8 ± 59.7 | 347.0 ± 52.9 | 0.33 | − | − | − |
BAP (mmol/L) | 2042.5 ± 240.7 | 2016.5 ± 267.3 | 2063.0 ± 217.4 | 0.45 | − | − | − |
AL (mm) | 24.9 ± 1.1 | 25.0 ± 1.1 | 24.9 ± 1.1 | 0.38 | 24.9 ± 1.1 | 25.0 ± 1.1 | 24.8 ± 1.1 |
IOP (mmHg) | 13.4 ± 3.4 | 14.1 ± 3.6 | 13.6 ± 3.5 | 0.32 | 14.3 ± 4.2 | 15.0 ± 4.5 | 13.8 ± 3.8 |
VA (logMAR) | −0.1 ± 0.2 | −0.1 ± 0.2 | −0.04 ± 0.2 | 0.15 | 0.03 ± 0.3 | 0.05 ± 0.35 | 0.01 ± 0.3 |
CpRNFLT (mm) | 83.3 ± 13.8 | 83.3 ± 14.9 | 83.3 ± 12.9 | 0.77 | 78.0 ± 13.5 | 76.3 ± 13.9 | 79.4 ± 13.2 |
MD (dB) | −8.4 ± 7.3 | −8.3 ± 7.6 | −8.57 ± 7.11 | 0.64 | −15.0 ± 8.1 | −15.8 ± 8.5 | −14.5 ± 7.8 |
wrgc × 1000 cells | 599.1 ± 268.3 | 614.5 ± 297.8 | 587.1 ± 244.11 | 0.76 | 426.6 ± 266.0 | 415.0 ± 301.6 | 435.7 ± 236.4 |
HL (%) | 19 (15.3) | 7 (12.7) | 12 (17.4) | 0.62* | − | − | − |
Diabetes (%) | 15 (12.1) | 12 (21.8) | 3 (4.3) | <0.01* | − | − | − |
Current smoker (%) | 16 (12.8) | 13 (23.6) | 3 (4.3) | <0.01* | − | − | − |